Ann Dermatol.  2011 Oct;23(Suppl 2):S151-S154. 10.5021/ad.2011.23.S2.S151.

Syringocystadenoma Papilliferum of the Back Combined with a Tubular Apocrine Adenoma

Affiliations
  • 1Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea. leejd@olmh.cuk.ac.kr

Abstract

Syringocystadenoma papilliferum (SCAP) and tubular apocrine adenoma (TAA) are rare benign sweat gland tumors. SCAP and TAA may have a histopathologic overlap, but few cases of a SCAP combined with a TAA have been reported. Herein we describe an unusual case of a SCAP co-existing with a TAA located on the back of a 12-year-old girl.

Keyword

Back; Syringocystadenoma papilliferum; Tubular apocrine adenoma

MeSH Terms

Adenoma
Child
Humans
Sweat Glands

Figure

  • Fig. 1 An erythematous well-defined and papillomatous plaque with superficial erosion and crust on the left side of the lower back.

  • Fig. 2 Views of the tumor. (A) The upper portion of the tumor had a cystic invagination that extends downward from the epidermis, and the lower portion exhibited islands of irregular-shaped tubular structures in the deep dermis at the excision specimen (H&E, ×20). (B) Two different epithelial cell layers lining the invaginated area and papillary projections in the upper portion of tumor. The luminal row consisted of high columnar cells showing active decapitation secretion, and the outer row consisted of small cuboidal cells. There was stromal infiltration of many plasma cells (H&E, ×400). (C) The numerous cystic and branching tubular structures in the dermis surrounded by a paucicellular fibrous stroma. The tubular structures have a dual or multilayered epithelium and the luminal cells showing evidence of active decapitation secretion in the dermis (H&E, ×100).


Reference

1. Taylor RS, Perone JB, Kaddu S, Kerl H. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Appendage tumors and hamartomas of the skin. Fitzpatrick's dermatology in general medicine. 2008. 7th ed. New York: McGraw Hill;1068–1087.
2. Ahmed TS, Priore JD, Seykora JT. Elder DE, Elenitsas R, Johnson BL, Murphy GF, Xu X, editors. Tumors of the epidermal appendages. Lever's histopathology of the skin. 2008. 10th ed. Philadelphia: Lippincott Williams & Wilkins;858–8602.
3. Toribio J, Zulaica A, Peteiro C. Tubular apocrine adenoma. J Cutan Pathol. 1987. 14:114–117.
Article
4. Ansai S, Watanabe S, Aso K. A case of tubular apocrine adenoma with syringocystadenoma papilliferum. J Cutan Pathol. 1989. 16:230–236.
Article
5. Epstein BA, Argenyi ZB, Goldstein G, Whitaker D. An unusual presentation of a congenital benign apocrine hamartoma. J Cutan Pathol. 1990. 17:53–58.
Article
6. Ishiko A, Shimizu H, Inamoto N, Nakmura K. Is tubular apocrine adenoma a distinct clinical entity? Am J Dermatopathol. 1993. 15:482–487.
Article
7. Aktepe F, Demir Y, Dilek FH. Tubular apocrine adenoma in association with syringocystadenoma papilliferum. Dermatol Online J. 2003. 9:7.
Article
8. Ahn BK, Park YK, Kim YC. A case of tubular apocrine adenoma with syringocystadenoma papilliferum arising in nevus sebaceus. J Dermatol. 2004. 31:508–510.
Article
9. Lee CK, Jang KT, Cho YS. Tubular apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canal. J Laryngol Otol. 2005. 119:1004–1006.
Article
10. Yamane N, Kato N, Yanagi T, Osawa R. Naevus sebaceus on the female breast accompanied with a tubular apocrine adenoma and a syringocystadenoma papilliferum. Br J Dermatol. 2007. 156:1397–1399.
Article
11. Vazmitel M, Michal M, Mukensnabl P, Kazakov DV. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case. Am J Dermatopathol. 2008. 30:51–53.
Article
12. Kim MS, Lee JH, Lee WM, Son SJ. A case of tubular apocrine adenoma with syringocystadenoma papilliferum that developed in a nevus sebaceus. Ann Dermatol. 2010. 22:319–322.
Article
13. Kazakov DV, Bisceglia M, Calonje E, Hantschke M, Kutzner H, Mentzel T, et al. Tubular adenoma and syringocystadenoma papilliferum: a reappraisal of their relationship. An interobserver study of a series, by a panel of dermatopathologists. Am J Dermatopathol. 2007. 29:256–263.
Article
14. Townsend TC, Bowen AR, Nobuhara KK. Syringocystadenoma papilliferum: an unusual cutaneous lesion in a pediatric patient. J Pediatr. 2004. 145:131–133.
Article
15. Hann SK, Choi YS, Choi EH. Syringocystadenoma papilliferum. Ann Dermatol. 1990. 2:100–104.
16. Requena L, Kiryu H, Ackerman AB. Neoplasms with apocrine differentiation. 1998. Philadelphia, PA: Lippicott-Raven.
17. James WD, Berger TG, Elston DM. Epidermal nevi, neoplasms, and cysts. Andrews' diseases of the skin clinical dermatology. 2006. 10th ed. Philadelphia: Elsevier;633–683.
18. Falck VG, Jordaan HF. Papillary eccrine adenoma. A tubulopapillary hidradenoma with eccrine differentiation. Am J Dermatopathol. 1986. 8:64–72.
19. Hsu PJ, Liu CH, Huang CJ. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor. J Cutan Pathol. 2003. 30:206–210.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr